Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion

Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and life-changing medications direct to patients

DURHAM, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the opening of its expanded non-commercial specialty pharmacy, FortreaRx™, located in Lake Mary, Florida, which offers advanced patient access solutions across the United States, including ambient and cold-chain distribution capabilities and expertise.

Licensed in all 50 states and U.S. territories, FortreaRx delivers flexible, scalable solutions that meet the specific needs of its customers while providing medications to patients who may otherwise not have access to them. Non-commercial specialty pharmacies, like FortreaRx, provide these solutions on behalf of their pharmaceutical manufacturer customers and are uniquely positioned to serve as a bridge between pharmaceutical manufacturers and patients who meet the manufacturer requirements for prescription assistance.

Since FortreaRx’s inception in late 2008, Fortrea has pioneered non-commercial specialty pharmacy services, focusing exclusively on the distribution of free-goods products as an integrated component of pharmaceutical manufacturer-sponsored patient assistance programs (PAP) designed to expand access to therapy for qualified patients with no health insurance or those who are underinsured. The FortreaRx 40,000-square-foot facility doubles its operational space and bolsters its capabilities, delivering:

  • 1,800 square feet of ambient storage
  • 6,000+ square feet of cold chain storage with more than 85 percent of prescriptions filled by FortreaRx requiring this unique handling
  • Greater processing and fulfillment space for up to 18,000 prescriptions daily
  • Enhanced shipping solutions with options for overnight, expedited and 2-day deliveries

“Fortrea’s well-established patient services offerings, combined with the expanded capabilities of FortreaRx, deliver an end-to-end approach, from early clinical stages to post-market delivery, ensuring a comprehensive and personalized experience for patients,” said Bill Nolan, vice president and global head of Patient Access at Fortrea. “From our expertise in broad-range disease states to our unwavering commitment to patient assistance, Fortrea excels at delivering timely and impactful solutions to our pharmaceutical sponsors that strive to reduce patient and provider challenges by streamlining enrollment processes and by offering full integration with broader patient support initiatives.”

FortreaRx’s call center hub of case managers seamlessly manages patient inquiries, counseling and data verification of prescriptions. Fortrea’s patient access team helps patients and providers understand and navigate the complexities of coverage while removing obstacles to get medication to patients.

FortreaRx delivers efficient, consultative and cost-effective solutions for manufacturer prescription programs typically resulting in significant yearly savings for patients.

For more information about FortreaRx and its services, please visit Fortrea.com.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of about 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter) @Fortrea.

Fortrea Contacts:
Fortrea Media: Galen Wilson – 703-298-0802, media@fortrea.com
Fortrea Media: Kate Dillon – 646-818-9115, kdillon@prosek.com

GlobeNewswire Distribution ID 9040223

Axi Select hailed as the future of prop trading as multiple demo account firms close doors due to pressures from regulators, brokers, and tech providers

Axi Select

Axi Select hailed as the future of prop trading as multiple demo account firms close doors due to pressures from regulators, brokers, and tech providers

SYDNEY, Australia, Feb. 20, 2024 (GLOBE NEWSWIRE) — Bucking the trend of recent negative developments in the prop firm industry, leading global CFD and FX broker Axi, which launched Axi Select – their unique capital allocation programme for talented traders – has been hailed by many industry experts as the future of the industry.

Recent issues experienced in the prop trading industry have resulted in multiple firms having to pause or close down their service due to pressure from regulators, partner brokers or tech providers.

Axi Select is completely different to the industry, and as a result has legitimised the prop firm model by offering a live trading account programme, with real controls in terms of execution, transparency, and fair market conditions. Since its launch in mid-2023, Axi Select has witnessed an incredible 40% month-on-month increase in the number of active clients on their platforms.

Axi believes their Select programme is revolutionary, sustainable and is the future of the prop firm model. Greg Rubin, Head of Axi Select, stated “In the last week the prop trading industry has been turned on its head completely with multiple firms having to suspend their services due to external pressures.

“We foresaw this, which is why we’ve developed a capital allocation programme which is built on our live trading account model and has been available in over 100 countries for more than 16 years. This has given us the confidence that Axi Select is a long-term solution to the prop trading community, and not subject to the issues now faced by prop firms who offer the demo account registration fee model and are under constant pressure from regulators and their tech partners.”

He continued “We genuinely empathise with the thousands of talented traders who will now be denied access to their allocated funds, and we encourage anyone using the demo trading registration model to question whether their prop firm partner will be able to continue as an ongoing concern given recent events. Unfortunately, this could be the beginning of the end for the demo account prop firm model.”

Axi Select offers a very attractive funding model – $1 million USD top allocation and clients can keep up to 90% of their profits – that’s one of the top allocation offerings worldwide, from an award-winning globally recognised, respected, and trusted broker.

By joining Axi you don’t need to pay a registration fee. Yes, you need to fund your trading account, but that money is yours to withdraw at any time and any profits you make on your funded account, you keep in addition to funds allocated by Axi.

“We believe passionately that Axi Select is the best allocation programme globally” said Rajesh Yohannan, Group CEO of Axi.

“By using a live trading account, with real money and the emotions that accompany this, we believe you are more likely to be profitable longer term and make money from your own live account as well as the funded proportion. Our Axi Select account has all the controls we offer to our live account holders globally. This includes access to our award-winning fast, transparent, and fair-trade execution.”

He added “If you are a talented trader and are looking for a legitimate funding programme which is designed to truly help you succeed and profit from the financial markets, and you want the stability of an account model which has been in market for 16 years, then Axi Select is the place for you to find your Edge.”

About Axi Select*

Axi Select* is a unique capital allocation programme that was specifically designed to help you succeed as a professional trader. Axi Select* offers a generous funding of up to $1 million USD as part of a structured and fair pathway to help you meet your long-term and most ambitious trading aspirations. Solidify your trading skills, knowledge and understanding of the markets and embark on your biggest trading journey ever with Axi through Axi Select.

Why Axi Select*?

  • 100% Free to join – No registration fees
  • Earn 90% of profits on $1,000,000 USD of our funds
  • Unrestrictive trading conditions & a structured pathway that provides a fair & real opportunity for traders to become professional traders
  • Trading score (Edge score) to assess & assist with trading performance
  • Dashboard with analytics, advanced stats, and a leader board
  • Exclusive online trading room with live analysis and learning videos from professional traders. Ability to interact with fellow traders and share analysis/trading ideas.
  • Trustworthy broker with over 35+ industry awards.

Axi

How is Axi Select* different from other programmes?

Programme Axi Select Industry Standard
Registration fee No Yes
Pass Evaluation No Yes
Restrictive Trading Conditions No Varies
Number of Attempts 3 1
Leverage 100:1 Varies, majority less than 100:1
Account Type Real Trading Account Demo
Additional Tools Dashboard/Leaderboard, Edge Score, Trading Room Varies

Learn more & switch to Axi Select: https://www.axi.com/select

* The Axi Select programme is only available to clients of AxiTrader Limited. CFDs carry a high risk of investment loss. In our dealings with you, we will act as a principal counterparty to all of your positions. This content is not available for AU, NZ, EU, and UK residents. For more information, refer to our Terms of Service. Other fees and minimum deposit apply.

About Axi

Axi is a global online FX and CFD trading company, trusted by thousands of ambitious customers in 100+ countries around the world. We help all types of traders, trading businesses, banks and financial organizations find the edge they need to achieve their financial goals through informed transactions made on the world’s financial markets. Axi offers a wide range of assets including CFDs for several asset classes including Forex, Shares, Gold, Silver, Oil, Coffee, Indices, and other commodities.

At Axi, we are proud of our reputation as an honest, fair, and trusted broker. Our many awards and ‘Great’ Trustpilot reviews prove we have earned the confidence of customers who value our outstanding service, fast execution, secure payments, segregated funds, and easy withdrawals.

For further enquiries contact service@axi.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4b7f4608-f090-471c-995d-de6c0f23438e

GlobeNewswire Distribution ID 1000914826

Death anniversary of Mushfiq Khwaja observed

The 19th death anniversary of Urdu poet, literary columnist, critic and distinguished researcher Mushfiq Khwaja was observed on Wednesday. Mushfiq Khwaja's original name was Khwaja Abdul Hai and he was born in Lahore. After securing M.A degree in Urdu from Karachi University, he got associated with 'Anjuman Taraqi Urdu'. Affiliation with 'Anjuman Taraqi Urdu' ignited Mushfiq Khwaja's personality and he carried out many important research achievements from this platform. In the 1980s, Mushfiq Khwaja started writing a literary column under the pen name of 'Khama Bagosh', which created a sensation in the entire subcontinent. All his life, Mushfiq Khwaja remained engaged in purely academic and research writing and compilation. Among his famous works and compilations are 'Tazkira-i-Khush Marka-i-Zaiba', 'Ghalib and Safeer Bilgrami', 'Jaiza-e-Makhtootaat-e-Urdu', 'Khama Bagosh Ke Qalam Se', 'Sukhan Dar Sukhan', 'Sukhan Haay Na Guftani', 'Sukhan Haay Gustarana', 'Aabiyaat'(poetry collection)' and Kulliyat-E-Yagan a'. Mushfiq Khwaja also wrote about fifty features on various topics for Radio Pakistan. He was conferred with the Presidential Medal in 1988 in recognition of his academic and literary services. Source: Radio Pakistan

ECP declares victory for 4 more MPAs of Balochistan, KP

The Election Commission of Pakistan has issued the success of four more members of the provincial assemblies of Khyber Pakhtunkhwa and Balochistan. According to a notification of ECP, Anwar Zeb Khan, running as an Independent, emerged victorious in PK-20, Bajaur-I. Ajmal Khan, also Independent, secured victory in PK-21, Bajaur-II. In PB-09, Kohlu, Nawab Jangayz Khan Mari of PML-N clinched victory. PK-40, Mansehra-V, was won by Sardar Shahjehan Yousaf, representing PML-N. Source: Radio Pakistan

One-Window Center established at NA for members-elect

The National Assembly Secretariat has established a one-window facilitation center to assist and support newly elected Members of the National Assembly. The center will operate from tomorrow 10:00 am to 3:00 pm, at the Parliament House in Islamabad. This facilitation center aims to provide various services, including official photos for their official cards and assisting in completing necessary documents. Source: Radio Pakistan

Madad Ali Sindhi calls for expanding domain of NAVTTC

Caretaker Minister for Federal Education and Professional Training, Madad Ali Sindhi, has directed to increase the disability and transgender quota in all National Vocational and Technical Training Commission (NAVTTC) programs. Chairing a meeting of NAVTTC in Islamabad today, he said that the domain of NAVTTC should be expanded to include provinces as well. He further emphasized the importance of including universities in expanding the scope of NAVTTC. Source: Radio Pakistan